Thymus hyperplasia following chemotherapy

Hyperplasia of the thymus, an uncommon development following chemotherapy, raises doubt concerning possible tumor recurrence. We report a case of thymic hyperplasia in a 12-year-old girl who was given chemotherapy for a cervicomediastinal lymphoma. Three months after treatment end, dry cough and an...

Full description

Saved in:
Bibliographic Details
Published inLa Presse médicale (1983) Vol. 25; no. 7; p. 291
Main Authors Cumin, I, Mechinaud, F, Harousseau, J L
Format Journal Article
LanguageFrench
Published France 24.02.1996
Subjects
Age Factors
Antineoplastic Agents - adverse effects
Child
Female
Humans
Prognosis
Thymus Hyperplasia - chemically induced
Thymus Hyperplasia - drug therapy
Online AccessGet more information

Cover

More Information
Summary:Hyperplasia of the thymus, an uncommon development following chemotherapy, raises doubt concerning possible tumor recurrence. We report a case of thymic hyperplasia in a 12-year-old girl who was given chemotherapy for a cervicomediastinal lymphoma. Three months after treatment end, dry cough and an enlargered mediastinum suggested recurrence, but histological examination of tissue biopsy demonstrated benign reactive hyperplasia. Outcome was favorable without recurrence after corticosteroid therapy. According to the literature, thymic hyperplasia is neither tumor nor treatment specific. It generally occurs in children but may be observed in young adults. Hyperplasia of the thymus following chemotherapy would appear to be a good prognosis factor.
ISSN:0755-4982